{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:32:06Z","timestamp":1794853926052,"version":"4.9.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T00:00:00Z","timestamp":1667606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T00:00:00Z","timestamp":1667606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Eesti Teadusagentuur","award":["COVSG2"],"award-info":[{"award-number":["COVSG2"]}]},{"name":"Eesti Teadusagentuur","award":["PRG629"],"award-info":[{"award-number":["PRG629"]}]},{"name":"Eesti Teadusagentuur","award":["PRG1496"],"award-info":[{"award-number":["PRG1496"]}]},{"DOI":"10.13039\/501100007821","name":"Tartu \u00dclikool","doi-asserted-by":"crossref","award":["PLTFYARENG53"],"award-info":[{"award-number":["PLTFYARENG53"]}],"id":[{"id":"10.13039\/501100007821","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008369","name":"Sihtasutus Archimedes","doi-asserted-by":"crossref","award":["TK141"],"award-info":[{"award-number":["TK141"]}],"id":[{"id":"10.13039\/100008369","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nanomaterials are prospective candidates for the elimination of viruses due to their multimodal mechanisms of action. Here, we tested the antiviral potential of a largely unexplored nanoparticle of cerium dioxide (CeO<jats:sub>2<\/jats:sub>). Two nano-CeO<jats:sub>2<\/jats:sub>with opposing surface charge, (+) and (\u2212), were assessed for their capability to decrease the plaque forming units (PFU) of four enveloped and two non-enveloped viruses during 1-h exposure. Statistically significant antiviral activity towards enveloped coronavirus SARS-CoV-2 and influenza virus was registered already at 20\u00a0mg Ce\/l. For other two enveloped viruses, transmissible gastroenteritis virus and bacteriophage \u03c66, antiviral activity was evidenced at 200\u00a0mg Ce\/l. As expected, the sensitivity of non-enveloped viruses towards nano-CeO<jats:sub>2<\/jats:sub>was significantly lower. EMCV picornavirus showed no decrease in PFU until the highest tested concentration, 2000\u00a0mg Ce\/l and MS2 bacteriophage showed slight non-monotonic response to high concentrations of nano-CeO<jats:sub>2<\/jats:sub>(\u2212). Parallel testing of antiviral activity of Ce<jats:sup>3+<\/jats:sup>ions and SiO<jats:sub>2<\/jats:sub>nanoparticles allows to conclude that nano-CeO<jats:sub>2<\/jats:sub>activity was neither due to released Ce-ions nor nonspecific effects of nanoparticulates. Moreover, we evidenced higher antiviral efficacy of nano-CeO<jats:sub>2<\/jats:sub>compared with Ag nanoparticles. This result along with low antibacterial activity and non-existent cytotoxicity of nano-CeO<jats:sub>2<\/jats:sub>allow us to propose CeO<jats:sub>2<\/jats:sub>nanoparticles for specific antiviral applications.<\/jats:p>","DOI":"10.1038\/s41598-022-23465-6","type":"journal-article","created":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T11:03:31Z","timestamp":1667646211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Antiviral efficacy of cerium oxide nanoparticles"],"prefix":"10.1038","volume":"12","author":[{"given":"Alexandra","family":"Nefedova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Rausalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Zusinaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Vanetsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merilin","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kairi","family":"Koppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stevin","family":"Lilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meeri","family":"Visnapuu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisjanis","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vambola","family":"Kisand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanel","family":"T\u00e4tte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Ivask","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,5]]},"reference":[{"key":"23465_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/B978-012373944-5.00178-4","volume-title":"Encyclopedia of Microbiology","author":"E Paintsil","year":"2009","unstructured":"Paintsil, E. & Cheng, Y.-C. Antiviral agents. In Encyclopedia of Microbiology (eds Paintsil, E. & Cheng, Y.-C.) 223\u2013257 (Elsevier, 2009). https:\/\/doi.org\/10.1016\/B978-012373944-5.00178-4."},{"key":"23465_CR2","doi-asserted-by":"publisher","first-page":"632677","DOI":"10.3389\/fphar.2021.632677","volume":"12","author":"O Indari","year":"2021","unstructured":"Indari, O., Jakhmola, S., Manivannan, E. & Jha, H. C. An update on antiviral therapy against SARS-CoV-2: How far have we come? Front. Pharmacol. 12, 632677 (2021).","journal-title":"Front. Pharmacol."},{"key":"23465_CR3","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/cplu.202000460","volume":"85","author":"L Liang","year":"2020","unstructured":"Liang, L., Ahamed, A., Ge, L., Fu, X. & Lisak, G. Advances in antiviral material development. ChemPlusChem 85, 2105\u20132128 (2020).","journal-title":"ChemPlusChem"},{"key":"23465_CR4","doi-asserted-by":"publisher","first-page":"110924","DOI":"10.1016\/j.msec.2020.110924","volume":"112","author":"L Chen","year":"2020","unstructured":"Chen, L. & Liang, J. An overview of functional nanoparticles as novel emerging antiviral therapeutic agents. Mater. Sci. Eng. C 112, 110924 (2020).","journal-title":"Mater. Sci. Eng. C"},{"key":"23465_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1039\/D0EN00980F","volume":"8","author":"CD Vecitis","year":"2021","unstructured":"Vecitis, C. D. Antiviral-nanoparticle interactions and reactions. Environ. Sci. Nano 8, 11\u201319 (2021).","journal-title":"Environ. Sci. Nano"},{"key":"23465_CR6","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3390\/nano10091645","volume":"10","author":"S Gurunathan","year":"2020","unstructured":"Gurunathan, S. et al. Antiviral potential of nanoparticles\u2014Can nanoparticles fight against coronaviruses? Nanomaterials 10, 1645 (2020).","journal-title":"Nanomaterials"},{"key":"23465_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2217\/nnm-2020-0441","volume":"16","author":"H Rashidzadeh","year":"2021","unstructured":"Rashidzadeh, H. et al. Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): Diagnosis, treatment, therapy and future perspectives. Nanomedicine 16, 497\u2013516 (2021).","journal-title":"Nanomedicine"},{"key":"23465_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.nano.2016.08.016","volume":"13","author":"T Yadavalli","year":"2017","unstructured":"Yadavalli, T. & Shukla, D. Role of metal and metal oxide nanoparticles as diagnostic and therapeutic tools for highly prevalent viral infections. Nanomed. Nanotechnol. Biol. Med. 13, 219\u2013230 (2017).","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"23465_CR9","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1007\/s12011-020-02414-2","volume":"199","author":"K Maduray","year":"2021","unstructured":"Maduray, K. & Parboosing, R. Metal nanoparticles: A promising treatment for viral and arboviral infections. Biol. Trace Elem. Res. 199, 3159\u20133176 (2021).","journal-title":"Biol. Trace Elem. Res."},{"key":"23465_CR10","doi-asserted-by":"publisher","unstructured":"Milovanovic, M., Arsenijevic, A., Milovanovic, J., Kanjevac, T. & Arsenijevic, N. Nanoparticles in antiviral therapy. In Antimicrobial Nanoarchitectonics, 383\u2013410. https:\/\/doi.org\/10.1016\/B978-0-323-52733-0.00014-8; https:\/\/web.archive.org\/web\/20220126201628\/; https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780323527330000148?via%3Dihub (Elsevier, 2017).","DOI":"10.1016\/B978-0-323-52733-0.00014-8"},{"key":"23465_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.idc.2010.01.001","volume":"24","author":"L Strasfeld","year":"2010","unstructured":"Strasfeld, L. & Chou, S. Antiviral drug resistance: Mechanisms and clinical implications. Infect. Dis. Clin. N. Am. 24, 413\u2013437 (2010).","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"23465_CR12","doi-asserted-by":"publisher","first-page":"e6315","DOI":"10.7717\/peerj.6315","volume":"7","author":"M Rosenberg","year":"2019","unstructured":"Rosenberg, M. et al. Potential ecotoxicological effects of antimicrobial surface coatings: A literature survey backed up by analysis of market reports. PeerJ 7, e6315 (2019).","journal-title":"PeerJ"},{"key":"23465_CR13","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3390\/nano10081566","volume":"10","author":"A Salleh","year":"2020","unstructured":"Salleh, A. et al. The potential of silver nanoparticles for antiviral and antibacterial applications: A mechanism of action. Nanomaterials 10, 1566 (2020).","journal-title":"Nanomaterials"},{"key":"23465_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1477-3155-8-15","volume":"8","author":"HH Lara","year":"2010","unstructured":"Lara, H. H., Ixtepan-Turrent, L., Garza-Trevi\u00f1o, E. N. & Rodriguez-Padilla, C. PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture. J. Nanobiotechnol. 8, 15 (2010).","journal-title":"J. Nanobiotechnol."},{"key":"23465_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-3155-8-1","volume":"8","author":"HH Lara","year":"2010","unstructured":"Lara, H. H., Ayala-Nu\u00f1ez, N. V., Ixtepan-Turrent, L. & Rodriguez-Padilla, C. Mode of antiviral action of silver nanoparticles against HIV-1. J. Nanobiotechnol. 8, 1 (2010).","journal-title":"J. Nanobiotechnol."},{"key":"23465_CR16","doi-asserted-by":"publisher","DOI":"10.1039\/b510984a","author":"RWY Sun","year":"2005","unstructured":"Sun, R. W. Y. et al. Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chem. Commun. https:\/\/doi.org\/10.1039\/b510984a (2005).","journal-title":"Chem. Commun."},{"key":"23465_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1477-3155-3-6","volume":"3","author":"JL Elechiguerra","year":"2005","unstructured":"Elechiguerra, J. L. et al. Interaction of silver nanoparticles with HIV-1. J. Nanobiotechnol. 3, 6 (2005).","journal-title":"J. Nanobiotechnol."},{"key":"23465_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/ijms19020387","volume":"19","author":"E Szyma\u0144ska","year":"2018","unstructured":"Szyma\u0144ska, E. et al. Multifunctional tannic acid\/silver nanoparticle-based mucoadhesive hydrogel for improved local treatment of HSV infection: In vitro and in vivo studies. IJMS 19, 387 (2018).","journal-title":"IJMS"},{"key":"23465_CR19","doi-asserted-by":"publisher","first-page":"105071","DOI":"10.1016\/j.micpath.2021.105071","volume":"158","author":"MJ Saadh","year":"2021","unstructured":"Saadh, M. J. et al. Silver nanoparticles with epigallocatechingallate and zinc sulphate significantly inhibits avian influenza A virus H9N2. Microb. Pathog. 158, 105071 (2021).","journal-title":"Microb. Pathog."},{"key":"23465_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.lwt.2017.01.065","volume":"79","author":"JL Castro-Mayorga","year":"2017","unstructured":"Castro-Mayorga, J. L. et al. Antiviral properties of silver nanoparticles against norovirus surrogates and their efficacy in coated polyhydroxyalkanoates systems. LWT Food Sci. Technol. 79, 503\u2013510 (2017).","journal-title":"LWT Food Sci. Technol."},{"key":"23465_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bbrc.2020.09.018","volume":"533","author":"SS Jeremiah","year":"2020","unstructured":"Jeremiah, S. S., Miyakawa, K., Morita, T., Yamaoka, Y. & Ryo, A. Potent antiviral effect of silver nanoparticles on SARS-CoV-2. Biochem. Biophys. Res. Commun. 533, 195\u2013200 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"23465_CR22","doi-asserted-by":"publisher","first-page":"1250g9","DOI":"10.1088\/2053-1591\/ab6ad8","volume":"6","author":"TTN Dung","year":"2020","unstructured":"Dung, T. T. N. et al. Silver nanoparticles as potential antiviral agents against African swine fever virus. Mater. Res. Express 6, 1250g9 (2020).","journal-title":"Mater. Res. Express"},{"key":"23465_CR23","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1128\/AEM.03427-13","volume":"80","author":"S Park","year":"2014","unstructured":"Park, S. et al. Antiviral properties of silver nanoparticles on a magnetic hybrid colloid. Appl. Environ. Microbiol. 80, 2343\u20132350 (2014).","journal-title":"Appl. Environ. Microbiol."},{"key":"23465_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11671-008-9128-2","volume":"3","author":"JV Rogers","year":"2008","unstructured":"Rogers, J. V., Parkinson, C. V., Choi, Y. W., Speshock, J. L. & Hussain, S. M. A preliminary assessment of silver nanoparticle inhibition of Monkeypox Virus plaque formation. Nanoscale Res. Lett. 3, 129\u2013133 (2008).","journal-title":"Nanoscale Res. Lett."},{"key":"23465_CR25","doi-asserted-by":"publisher","first-page":"365101","DOI":"10.1088\/1361-6528\/ac03d6","volume":"32","author":"TR Sinclair","year":"2021","unstructured":"Sinclair, T. R. et al. Surface chemistry-dependent antiviral activity of silver nanoparticles. Nanotechnology 32, 365101 (2021).","journal-title":"Nanotechnology"},{"key":"23465_CR26","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/wnan.1707","volume":"13","author":"F Pilaquinga","year":"2021","unstructured":"Pilaquinga, F., Morey, J., Torres, M., Seqqat, R. & de las Pi\u00f1a, M. N. Silver nanoparticles as a potential treatment against SARS-CoV-2: A review. WIREs Nanomed. Nanobiotechnol. 13, 1707 (2021).","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"23465_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1049\/mnl.2017.0648","volume":"13","author":"K Kalwar","year":"2018","unstructured":"Kalwar, K. & Shan, D. Antimicrobial effect of silver nanoparticles (AgNPs) and their mechanism\u2014A mini review. Micro Nano Lett. 13, 277\u2013280 (2018).","journal-title":"Micro Nano Lett."},{"key":"23465_CR28","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.3390\/ijms21072375","volume":"21","author":"Z Ferdous","year":"2020","unstructured":"Ferdous, Z. & Nemmar, A. Health impact of silver nanoparticles: A review of the biodistribution and toxicity following various routes of exposure. Int. J. Mol. Sci. 21, 2375 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"23465_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1166\/jbns.2012.1084","volume":"6","author":"V Lozovski","year":"2012","unstructured":"Lozovski, V. et al. Physical point of view for antiviral effect caused by the interaction between the viruses and nanoparticles. J. Bionanosci. 6, 109\u2013112 (2012).","journal-title":"J. Bionanosci."},{"key":"23465_CR30","first-page":"42","volume":"72","author":"NM Zholobak","year":"1993","unstructured":"Zholobak, N. M. et al. Antiviral effect of cerium dioxide nanoparticles stabilized by low-molecular polyacrylic acid. Mikrobiolohichnyi zhurnal (Ukraine) 72, 42\u201347 (1993).","journal-title":"Mikrobiolohichnyi zhurnal (Ukraine)"},{"key":"23465_CR31","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2217\/nnm-2019-0368","volume":"15","author":"HEA Mohamed","year":"2020","unstructured":"Mohamed, H. E. A. et al. Promising antiviral, antimicrobial and therapeutic properties of green nanoceria. Nanomedicine 15, 467\u2013488 (2020).","journal-title":"Nanomedicine"},{"key":"23465_CR32","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1021\/cm061580n","volume":"18","author":"P Dutta","year":"2006","unstructured":"Dutta, P. et al. Concentration of Ce3+ and oxygen vacancies in cerium oxide nanoparticles. Chem. Mater. 18, 5144\u20135146 (2006).","journal-title":"Chem. Mater."},{"key":"23465_CR33","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1021\/acsami.0c19414","volume":"13","author":"P Lyu","year":"2021","unstructured":"Lyu, P. et al. Self-driven reactive oxygen species generation via interfacial oxygen vacancies on carbon-coated TiO2\u2013x with versatile applications. ACS Appl. Mater. Interfaces 13, 2033\u20132043 (2021).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"23465_CR34","doi-asserted-by":"publisher","first-page":"102226","DOI":"10.1016\/j.isci.2021.102226","volume":"24","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Regulation of Ce (III)\/Ce (IV) ratio of cerium oxide for antibacterial application. iScience 24, 102226 (2021).","journal-title":"iScience"},{"key":"23465_CR35","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1021\/nn800511k","volume":"2","author":"T Xia","year":"2008","unstructured":"Xia, T. et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2, 2121\u20132134 (2008).","journal-title":"ACS Nano"},{"key":"23465_CR36","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1021\/nn200126a","volume":"5","author":"I Celardo","year":"2011","unstructured":"Celardo, I. et al. Ce3+ ions determine redox-dependent anti-apoptotic effect of cerium oxide nanoparticles. ACS Nano 5, 4537\u20134549 (2011).","journal-title":"ACS Nano"},{"key":"23465_CR37","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12885-016-2206-4","volume":"16","author":"M Hijaz","year":"2016","unstructured":"Hijaz, M. et al. Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer. BMC Cancer 16, 220 (2016).","journal-title":"BMC Cancer"},{"key":"23465_CR38","doi-asserted-by":"publisher","first-page":"9408","DOI":"10.1002\/anie.201805052","volume":"57","author":"HJ Kwon","year":"2018","unstructured":"Kwon, H. J. et al. Ceria nanoparticle systems for selective scavenging of mitochondrial, intracellular, and extracellular reactive oxygen species in Parkinson\u2019s disease. Angew. Chem. Int. Ed. 57, 9408\u20139412 (2018).","journal-title":"Angew. Chem. Int. Ed."},{"key":"23465_CR39","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1021\/acs.accounts.0c00280","volume":"53","author":"Y Yang","year":"2020","unstructured":"Yang, Y., Zhang, M., Song, H. & Yu, C. Silica-based nanoparticles for biomedical applications: From nanocarriers to biomodulators. Acc. Chem. Res. 53, 1545\u20131556 (2020).","journal-title":"Acc. Chem. Res."},{"key":"23465_CR40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.colsurfa.2017.05.059","volume":"529","author":"J Calvache-Mu\u00f1oz","year":"2017","unstructured":"Calvache-Mu\u00f1oz, J., Prado, F. A. & Rodr\u00edguez-P\u00e1ez, J. E. Cerium oxide nanoparticles: Synthesis, characterization and tentative mechanism of particle formation. Colloids Surf. A 529, 146\u2013159 (2017).","journal-title":"Colloids Surf. A"},{"key":"23465_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1080\/17458080.2011.557841","volume":"8","author":"JC Mohan","year":"2013","unstructured":"Mohan, J. C., Praveen, G., Chennazhi, K. P., Jayakumar, R. & Nair, S. V. Functionalised gold nanoparticles for selective induction of in vitro apoptosis among human cancer cell lines. J. Exp. Nanosci. 8, 32\u201345 (2013).","journal-title":"J. Exp. Nanosci."},{"key":"23465_CR42","doi-asserted-by":"publisher","first-page":"22615","DOI":"10.1021\/acs.jpcc.6b05650","volume":"120","author":"TV Plakhova","year":"2016","unstructured":"Plakhova, T. V. et al. Solubility of nanocrystalline cerium dioxide: Experimental data and thermodynamic modeling. J. Phys. Chem. C 120, 22615\u201322626 (2016).","journal-title":"J. Phys. Chem. C"},{"key":"23465_CR43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/viw2.16","volume":"1","author":"Q Lin","year":"2020","unstructured":"Lin, Q. et al. Sanitizing agents for virus inactivation and disinfection. View 1, 16 (2020).","journal-title":"View"},{"key":"23465_CR44","unstructured":"ISO Standard 21702:2019. Measurement of Antiviral Activity on Plastics and Other Non-porous Surfaces (2019)."},{"key":"23465_CR45","unstructured":"ISO Standard 18184:2019. Textiles\u2014Determination of Antiviral Activity of Textile Products (2019)."},{"key":"23465_CR46","doi-asserted-by":"publisher","first-page":"12011","DOI":"10.1128\/JVI.01316-10","volume":"84","author":"W-C Liu","year":"2010","unstructured":"Liu, W.-C., Lin, S.-C., Yu, Y.-L., Chu, C.-L. & Wu, S.-C. Dendritic cell activation by recombinant hemagglutinin proteins of H1N1 and H5N1 influenza A viruses. J. Virol. 84, 12011\u201312017 (2010).","journal-title":"J. Virol."},{"key":"23465_CR47","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0168-1702(87)90008-6","volume":"8","author":"L Jacobs","year":"1987","unstructured":"Jacobs, L., de Groot, R., van der Zeijst, B. A. M., Horzinek, M. C. & Spaan, W. The nucleotide sequence of the peplomer gene of porcine transmissible gastroenteritis virus (TGEV): Comparison with the sequence of the peplomer protein of feline infectious peritonitis virus (FIPV). Virus Res. 8, 363\u2013371 (1987).","journal-title":"Virus Res."},{"key":"23465_CR48","doi-asserted-by":"publisher","first-page":"351","DOI":"10.4161\/viru.20573","volume":"3","author":"M Carocci","year":"2012","unstructured":"Carocci, M. & Bakkali-Kassimi, L. The encephalomyocarditis virus. Virulence 3, 351\u2013367 (2012).","journal-title":"Virulence"},{"key":"23465_CR49","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/genetics\/147.3.953","volume":"147","author":"L Chao","year":"1997","unstructured":"Chao, L., Tran, T. T. & Tran, T. T. The advantage of sex in the RNA virus \u03c66. Genetics 147, 953\u2013959 (1997).","journal-title":"Genetics"},{"key":"23465_CR50","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0005-2787(81)90179-9","volume":"654","author":"T Shiba","year":"1981","unstructured":"Shiba, T. & Suzuki, Y. Localization of A protein in the RNA-A protein complex of RNA phage MS2. Biochim. Biophys. Acta Nucleic Acids Protein Synth. 654, 249\u2013255 (1981).","journal-title":"Biochim. Biophys. Acta Nucleic Acids Protein Synth."},{"key":"23465_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1128\/AEM.01482-20","volume":"86","author":"C Whitworth","year":"2020","unstructured":"Whitworth, C. et al. Persistence of bacteriophage Phi 6 on porous and nonporous surfaces and the potential for its use as an ebola virus or coronavirus surrogate. Appl. Environ. Microbiol. 86, 20 (2020).","journal-title":"Appl. Environ. Microbiol."},{"key":"23465_CR52","doi-asserted-by":"publisher","first-page":"8692","DOI":"10.1021\/acs.est.7b01296","volume":"51","author":"NA de Carvalho","year":"2017","unstructured":"de Carvalho, N. A., Stachler, E. N., Cimabue, N. & Bibby, K. Evaluation of Phi6 persistence and suitability as an enveloped virus surrogate. Environ. Sci. Technol. 51, 8692\u20138700 (2017).","journal-title":"Environ. Sci. Technol."},{"key":"23465_CR53","doi-asserted-by":"publisher","first-page":"22419","DOI":"10.1038\/s41598-020-79625-z","volume":"10","author":"A Fedorenko","year":"2020","unstructured":"Fedorenko, A., Grinberg, M., Orevi, T. & Kashtan, N. Survival of the enveloped bacteriophage Phi6 (a surrogate for SARS-CoV-2) in evaporated saliva microdroplets deposited on glass surfaces. Sci. Rep. 10, 22419 (2020).","journal-title":"Sci. Rep."},{"key":"23465_CR54","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1089\/fpd.2009.0426","volume":"7","author":"DH D\u2019Souza","year":"2010","unstructured":"D\u2019Souza, D. H. & Su, X. Efficacy of chemical treatments against murine norovirus, feline calicivirus, and MS2 bacteriophage. Foodborne Pathog. Dis. 7, 319\u2013326 (2010).","journal-title":"Foodborne Pathog. Dis."},{"key":"23465_CR55","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ecoenv.2014.01.002","volume":"101","author":"J Kim","year":"2014","unstructured":"Kim, J. et al. Non-monotonic concentration\u2013response relationship of TiO2 nanoparticles in freshwater cladocerans under environmentally relevant UV-A light. Ecotoxicol. Environ. Saf. 101, 240\u2013247 (2014).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"23465_CR56","doi-asserted-by":"publisher","first-page":"4944","DOI":"10.1021\/acs.est.6b06618","volume":"51","author":"T Klanj\u0161\u010dek","year":"2017","unstructured":"Klanj\u0161\u010dek, T., Muller, E. B., Holden, P. A. & Nisbet, R. M. Host\u2013symbiont interaction model explains non-monotonic response of soybean growth and seed production to nano-CeO2 exposure. Environ. Sci. Technol. 51, 4944\u20134950 (2017).","journal-title":"Environ. Sci. Technol."},{"key":"23465_CR57","doi-asserted-by":"publisher","first-page":"6350","DOI":"10.1021\/es100100p","volume":"44","author":"BD Gusseme","year":"2010","unstructured":"Gusseme, B. D. et al. Virus removal by biogenic cerium. Environ. Sci. Technol. 44, 6350\u20136356 (2010).","journal-title":"Environ. Sci. Technol."},{"key":"23465_CR58","doi-asserted-by":"publisher","first-page":"14544","DOI":"10.1021\/acsnano.1c04142","volume":"15","author":"CJ Neal","year":"2021","unstructured":"Neal, C. J. et al. Metal-mediated nanoscale cerium oxide inactivates human coronavirus and rhinovirus by surface disruption. ACS Nano 15, 14544\u201314556 (2021).","journal-title":"ACS Nano"},{"key":"23465_CR59","unstructured":"FDA Code of Federal Regulations Title 21. U.S. Food & Drug Administration, 21 CFR Part 582."},{"key":"23465_CR60","unstructured":"FDA Code of Federal Regulations Title 21. U.S. Food & Drug Administration, 21 CFR Part 184."},{"key":"23465_CR61","doi-asserted-by":"publisher","first-page":"7720","DOI":"10.1166\/jnn.2016.12828","volume":"16","author":"SS Agnihothram","year":"2016","unstructured":"Agnihothram, S. S. et al. Silicon dioxide impedes antiviral response and causes genotoxic insult during calicivirus replication. J. Nanosci. Nanotechnol. 16, 7720\u20137730 (2016).","journal-title":"J. Nanosci. Nanotechnol."},{"key":"23465_CR62","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s50070","author":"S Galdiero","year":"2013","unstructured":"Galdiero, S. et al. Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3. Int. J. Nanomed. https:\/\/doi.org\/10.2147\/ijn.s50070 (2013).","journal-title":"Int. J. Nanomed."},{"key":"23465_CR63","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1556-276X-8-93","volume":"8","author":"Y Mori","year":"2013","unstructured":"Mori, Y. et al. Antiviral activity of silver nanoparticle\/chitosan composites against H1N1 influenza A virus. Nanoscale Res. Lett. 8, 93 (2013).","journal-title":"Nanoscale Res. Lett."},{"key":"23465_CR64","volume-title":"Guidance on the Biocidal Products Regulation. Volume II, Efficacy. Assessment and Evaluation (Parts B+C)","author":"European Chemicals Agency","year":"2018","unstructured":"European Chemicals Agency. Guidance on the Biocidal Products Regulation. Volume II, Efficacy. Assessment and Evaluation (Parts B+C) (Publications Office, 2018)."},{"key":"23465_CR65","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fmats.2020.00213","volume":"7","author":"M Qi","year":"2020","unstructured":"Qi, M. et al. Cerium and its oxidant-based nanomaterials for antibacterial applications: A state-of-the-art review. Front. Mater. 7, 213 (2020).","journal-title":"Front. Mater."},{"key":"23465_CR66","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1021\/es9002444","volume":"43","author":"KV Hoecke","year":"2009","unstructured":"Hoecke, K. V. et al. Fate and effects of CeO2 nanoparticles in aquatic ecotoxicity tests. Environ. Sci. Technol. 43, 4537\u20134546 (2009).","journal-title":"Environ. Sci. Technol."},{"key":"23465_CR67","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/bit.21525","volume":"98","author":"N Link","year":"2007","unstructured":"Link, N., Brunner, T. J., Dreesen, I. A. J., Stark, W. J. & Fussenegger, M. Inorganic nanoparticles for transfection of mammalian cells and removal of viruses from aqueous solutions. Biotechnol. Bioeng. 98, 1083\u20131093 (2007).","journal-title":"Biotechnol. Bioeng."},{"key":"23465_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1923606","volume":"2018","author":"IAP Farias","year":"2018","unstructured":"Farias, I. A. P., dos Santos, C. C. L. & Sampaio, F. C. Antimicrobial activity of cerium oxide nanoparticles on opportunistic microorganisms: A systematic review. Biomed. Res. Int. 2018, 1\u201314 (2018).","journal-title":"Biomed. Res. Int."},{"key":"23465_CR69","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10616-014-9701-8","volume":"67","author":"MM Masadeh","year":"2015","unstructured":"Masadeh, M. M. et al. Cerium oxide and iron oxide nanoparticles abolish the antibacterial activity of ciprofloxacin against gram positive and gram negative biofilm bacteria. Cytotechnology 67, 427\u2013435 (2015).","journal-title":"Cytotechnology"},{"key":"23465_CR70","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S2222-1808(12)60022-X","volume":"2","author":"S Ravikumar","year":"2012","unstructured":"Ravikumar, S., Gokulakrishnan, R. & Boomi, P. In vitro antibacterial activity of the metal oxide nanoparticles against urinary tract infectious bacterial pathogens. Asian Pac. J. Trop. Dis. 2, 85\u201389 (2012).","journal-title":"Asian Pac. J. Trop. Dis."},{"key":"23465_CR71","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1515\/ijcre-2012-0055","volume":"11","author":"R Cuahtecontzi-Delint","year":"2013","unstructured":"Cuahtecontzi-Delint, R. et al. Enhanced antibacterial activity of CeO2 nanoparticles by surfactants. Int. J. Chem. Reactor Eng. 11, 781\u2013785 (2013).","journal-title":"Int. J. Chem. Reactor Eng."},{"key":"23465_CR72","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1021\/es060999b","volume":"40","author":"A Thill","year":"2006","unstructured":"Thill, A. et al. Cytotoxicity of CeO2 nanoparticles for Escherichia coli. Physico-chemical insight of the cytotoxicity mechanism. Environ. Sci. Technol. 40, 6151\u20136156 (2006).","journal-title":"Environ. Sci. Technol."},{"key":"23465_CR73","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12951-017-0308-z","volume":"15","author":"YN Slavin","year":"2017","unstructured":"Slavin, Y. N., Asnis, J., H\u00e4feli, U. O. & Bach, H. Metal nanoparticles: Understanding the mechanisms behind antibacterial activity. J. Nanobiotechnol. 15, 65 (2017).","journal-title":"J. Nanobiotechnol."},{"key":"23465_CR74","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.materresbull.2014.11.029","volume":"62","author":"A Xie","year":"2015","unstructured":"Xie, A. et al. Rapid hydrothermal synthesis of CeO2 nanoparticles with (220)-dominated surface and its CO catalytic performance. Mater. Res. Bull. 62, 148\u2013152 (2015).","journal-title":"Mater. Res. Bull."},{"key":"23465_CR75","doi-asserted-by":"publisher","first-page":"106141","DOI":"10.1039\/C6RA18566E","volume":"6","author":"AL Popov","year":"2016","unstructured":"Popov, A. L. et al. Radioprotective effects of ultra-small citrate-stabilized cerium oxide nanoparticles in vitro and in vivo. RSC Adv. 6, 106141\u2013106149 (2016).","journal-title":"RSC Adv."},{"key":"23465_CR76","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/adfm.200800233","volume":"18","author":"D Aherne","year":"2008","unstructured":"Aherne, D., Ledwith, D. M., Gara, M. & Kelly, J. M. Optical properties and growth aspects of silver nanoprisms produced by a highly reproducible and rapid synthesis at room temperature: Silver nanoprisms from rapid, reproducible, room-temperature synthesis. Adv. Funct. Mater. 18, 2005\u20132016 (2008).","journal-title":"Adv. Funct. Mater."},{"key":"23465_CR77","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ceramint.2016.09.133","volume":"43","author":"Q Guo","year":"2017","unstructured":"Guo, Q. et al. Synthesis of disperse amorphous SiO2 nanoparticles via sol\u2013gel process. Ceram. Int. 43, 192\u2013196 (2017).","journal-title":"Ceram. Int."},{"key":"23465_CR78","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1017\/S002217240001158X","volume":"38","author":"AA Miles","year":"1938","unstructured":"Miles, A. A., Misra, S. S. & Irwin, J. O. The estimation of the bactericidal power of the blood. Epidemiol. Infect. 38, 732\u2013749 (1938).","journal-title":"Epidemiol. Infect."},{"key":"23465_CR79","unstructured":"SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks of the European Commission)\u2014Opinion on the Appropriateness of Existing Methodologies to Assess the Potential Risks Associated with Engineered and Adventitious Products of Nanotechnologies. Adopted by the SCENIHR During the 7th Plenary Meeting of 28\u201329 SEPTEMBER 2005 (2005)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23465-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23465-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23465-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T04:46:11Z","timestamp":1701319571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23465-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,5]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["23465"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-23465-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,5]]},"assertion":[{"value":"17 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18746"}}